Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SARSTEDT AS
AS
Active
Org 947818678
Rosenholmveien 25, 1414 Trollåsen
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1988
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 32,7M
+18% vs 2024
EBITDA margin
9.0%
+101% vs 2024
Equity ratio
81.5%
Financial strength
Net profit 2025
NOK 2,9M
+174% vs 2024
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
2M
2021
1M
-50%
2022
2M
+100%
2023
1M
-50%
2024
3M
+200%
2025
Key figures
Annual report 2025
Revenue
NOK 32,7M
+18%
EBITDA
NOK 3M
+101%
Net profit
NOK 2,9M
+174%
Total assets
NOK 19,8M
+1%
Equity
NOK 16,2M
+22%
Employees
5
—
Company information
Legal name
SARSTEDT AS
Org number
947818678
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. juli 1988
Share capital
NOK 1 000 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Contact
Address
Rosenholmveien 25, 1414 Trollåsen
Phone
+4764856820
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Nordre Follo
All Norway companies
Revenue
NOK millions
0M
9M
19M
28M
38M
28M
2021
26M
2022
32M
2023
28M
2024
33M
2025
EBITDA
NOK millions
0M
1M
2M
3M
3M
2M
2021
1M
2022
2M
2023
1M
2024
3M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
27 692
26 060
31 535
27 747
32 687
Staff expenses
−3 233
−3 477
−3 878
−3 975
−5 309
EBITDA
2 368
1 219
2 259
1 472
2 957
Depreciation & amort.
−10
−10
−6
−0
−0
EBIT
2 358
1 209
2 253
1 472
2 957
Net financials
94
36
−29
195
315
Profit before tax
2 452
1 245
2 224
1 667
3 272
Tax
229
273
566
596
338
Net profit
2 223
972
1 657
1 071
2 934
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
13 782
14 322
18 233
19 650
19 824
Equity
9 517
10 489
12 146
13 217
16 151
Long-term debt
0
0
0
0
−56
Short-term debt
4 227
3 782
6 036
6 383
3 618
Total debt
4 227
3 782
6 036
6 383
3 618
Financial ratios
5-year trend
EBITDA margin
9.0%
This company
15.8%
Market median
-43% vs market
2021
2025
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
2021
2025
Return on equity
18.2%
This company
18.4%
Market median
+1% vs market
2021
2025
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
2021
2025
Asset turnover
1.65×
This company
1.12×
Market median
+47% vs market
2021
2025
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MN
Monika Neuman
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
TS
Timo Schretzmair
Chairman
2015
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Sarstedt Holding Gmbh
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of SARSTEDT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Monika Neuman
Chief Executive Officer
0 companies
Timo Schretzmair
Chairman
0 companies